JPS5592316A - Cholesterol-lowering agent - Google Patents

Cholesterol-lowering agent

Info

Publication number
JPS5592316A
JPS5592316A JP16290078A JP16290078A JPS5592316A JP S5592316 A JPS5592316 A JP S5592316A JP 16290078 A JP16290078 A JP 16290078A JP 16290078 A JP16290078 A JP 16290078A JP S5592316 A JPS5592316 A JP S5592316A
Authority
JP
Japan
Prior art keywords
cholesterol
lowering agent
acid
derivative
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16290078A
Other languages
Japanese (ja)
Inventor
Shigeru Tokiwa
Akio Kanazawa
Shinichi Tejima
Yoshiji Kajiwara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAGAKUHIN KENSA KIYOUKAI
KAGAKUHIN KENSA KYOKAI
Original Assignee
KAGAKUHIN KENSA KIYOUKAI
KAGAKUHIN KENSA KYOKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAGAKUHIN KENSA KIYOUKAI, KAGAKUHIN KENSA KYOKAI filed Critical KAGAKUHIN KENSA KIYOUKAI
Priority to JP16290078A priority Critical patent/JPS5592316A/en
Publication of JPS5592316A publication Critical patent/JPS5592316A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: A cholesterol-lowering agent capable of exhibiting a rapid action even in a very small amount, free from side effects, comprising a ≥20C long-chain highly unsaturated fatty acid having 3 or more double bonds in one molecule and its derivative or their mixture.
CONSTITUTION: A cholesterol-lowering agent comprising a ≥20C long-chain highly unsaturated fatty acid having 3 or more double bonds in one molecule, its derivative, or their mixture in various dosage forms, e.g. liquid, powder or granules. Eicosatrienoic or docosatetraenoic acid may be cited as the acid.
COPYRIGHT: (C)1980,JPO&Japio
JP16290078A 1978-12-29 1978-12-29 Cholesterol-lowering agent Pending JPS5592316A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16290078A JPS5592316A (en) 1978-12-29 1978-12-29 Cholesterol-lowering agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16290078A JPS5592316A (en) 1978-12-29 1978-12-29 Cholesterol-lowering agent

Publications (1)

Publication Number Publication Date
JPS5592316A true JPS5592316A (en) 1980-07-12

Family

ID=15763364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16290078A Pending JPS5592316A (en) 1978-12-29 1978-12-29 Cholesterol-lowering agent

Country Status (1)

Country Link
JP (1) JPS5592316A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010429A1 (en) * 1990-01-09 1991-07-25 Kabushiki Kaisya Advance Lipid absorption inhibiting composition
WO1999045916A3 (en) * 1998-03-10 1999-11-11 Beth Israel Hospital Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010429A1 (en) * 1990-01-09 1991-07-25 Kabushiki Kaisya Advance Lipid absorption inhibiting composition
WO1999045916A3 (en) * 1998-03-10 1999-11-11 Beth Israel Hospital Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
US6180671B1 (en) 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US6552081B1 (en) 1998-03-10 2003-04-22 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected

Similar Documents

Publication Publication Date Title
JPS5279794A (en) Piezo-vibrator unit
JPS5592316A (en) Cholesterol-lowering agent
JPS5238507A (en) Detergent composition
JPS5238508A (en) Liquid detergent composition
JPS5236107A (en) Liquid detergent composition
JPS5228942A (en) Pesticide composition with durable actions
JPS5379904A (en) High-concentration liquid detergnet composition
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS56122312A (en) Hepatic cholesterol-lowering agent (hepatic decholesterolizing agent)
JPS5423132A (en) Analgesic composition
JPS5270035A (en) Gel-form perfumery composition
JPS5259606A (en) Liquid detergent composition
JPS5238506A (en) Detergent composition
JPS5234921A (en) Fungicidal composition
JPS53130631A (en) Novel hydroxybenzoic acid ester and bacteriostatic agent containing the same as effective component
JPS5423131A (en) Pharmaceutical composition containing acetylsalicylic acid and ethenzamide
JPS5260810A (en) Detergent composition
JPS5257114A (en) Process for ether-containing acrylic acid ester or methacrylic acid es ter
JPS5261291A (en) Preparation of fr-29611 substance and/or fr-29612 substance
JPS5373208A (en) Liquid detergent composition
JPS55153719A (en) Tranquilizer
JPS5248640A (en) Process for preparation of alpha-substituted-phenyl-alkane-carboxylic acids their derivatives
JPS51125253A (en) Preparation of polymerizable composition
JPS5226550A (en) Composite stabilizer compositions
JPS5251029A (en) Phromone composition